Back
Aligos Therapeutics Stock Price Chart
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Sell
37
ALGS
Aligos Therapeutics
Last Price:
$33.58
Seasonality Move:
-18.25%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free-
The current trend is moderately bearish and ALGS is experiencing slight buying pressure.
Aligos Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.27 | Sell |
| 20-day SMA: | 38.29 | Sell |
| 50-day SMA: | 26.47 | Buy |
| 200-day SMA: | 17.28 | Buy |
| 8-day EMA: | 39.15 | Sell |
| 20-day EMA: | 37.02 | Sell |
| 50-day EMA: | 29.21 | Buy |
| 200-day EMA: | 20.02 | Buy |
Aligos Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.65 | Buy |
| Relative Strength Index (14 RSI): | 47.68 | Sell |
| Chaikin Money Flow: | 162310 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.97 - 41.57) | Sell |
| Bollinger Bands (100): | (7.01 - 29.97) | Buy |
Aligos Therapeutics Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 33.71 while ALGS 8-day simple moving average is 40.27, which is a Sell signal.
-
The stock price of ALGS is 33.71 while Aligos Therapeutics 20-day SMA is 38.29, which makes it a Sell.
-
Aligos Therapeutics 50-day simple moving average is 26.47 while ALGS share price is 33.71, making it a Buy technically.
-
ALGS stock price is 33.71 and Aligos Therapeutics 200-day simple moving average is 17.28, creating a Buy signal.
ALGS Technical Analysis vs Fundamental Analysis
Sell
37
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a SellThe current Aligos Therapeutics [ALGS] share price is $33.71. The Score for ALGS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
120.9M
Price in USD:
33.71
Share Volume:
665.5K
Aligos Therapeutics 52-Week Range
52-Week High:
46.80
52-Week Low:
6.76
Sell
37
Aligos Therapeutics (ALGS)
is a Sell
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?The Aligos Therapeutics stock price is 33.71 USD today.
-
Will ALGS stock go up or go down?Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aligos Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is overvalued.
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 33.71 while ALGS 8-day exponential moving average is 39.15, which is a Sell signal.
-
The stock price of ALGS is 33.71 while Aligos Therapeutics 20-day EMA is 37.02, which makes it a Sell.
-
Aligos Therapeutics 50-day exponential moving average is 29.21 while ALGS share price is 33.71, making it a Buy technically.
-
ALGS stock price is 33.71 and Aligos Therapeutics 200-day simple moving average is 20.02, creating a Buy signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
-
ALGS Moving Average Covergence Divergence (MACD) indicator is 3.65, suggesting Aligos Therapeutics is a Buy
-
Aligos Therapeutics Relative Strength Index (RSI) is 47.68, which suggest Aligos Therapeutics is oversold
-
The Bollinger Bands (25) for Aligos Therapeutics is (30.97 - 41.57), which suggest Aligos Therapeutics is a Buy
-
The Bollinger Bands (100) for Aligos Therapeutics is (7.01 - 29.97), which suggest Aligos Therapeutics is a Buy
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.